The impact of comorbidity identification on outcomes in patients with pyoderma gangrenosum: A retrospective cohort study of previously hospitalized patients

Manisha Ravi; John Trinidad; Natalie Spaccarelli; Benjamin Kaffenberger

doi:10.1016/j.jaad.2021.07.032

The impact of comorbidity identification on outcomes in patients with pyoderma gangrenosum: A retrospective cohort study of previously hospitalized patients

Manisha Ravi
, John Trinidad
, Natalie Spaccarelli
, Benjamin Kaffenberger

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	194-197
Number of pages	4
Journal	Journal of the American Academy of Dermatology
Volume	87
Issue number	1
DOIs	https://doi.org/10.1016/j.jaad.2021.07.032
State	Published - Jul 2022

Access to Document

10.1016/j.jaad.2021.07.032

Cite this

@article{fa4c8ecc33714118bc04be37216247b4,

title = "The impact of comorbidity identification on outcomes in patients with pyoderma gangrenosum: A retrospective cohort study of previously hospitalized patients",

author = "Manisha Ravi and John Trinidad and Natalie Spaccarelli and Benjamin Kaffenberger",

note = "Funding Information: Dr Kaffenberger is an investigator for AnaptysBio Inc, Biogen, InflaRx, Onquality Pharmaceuticals, and Eli Lilly Co and is funded by the Dermatology Foundation . Drs Trinidad and Spaccarelli and Author Ravi have no conflicts of interest to declare.",

year = "2022",

month = jul,

doi = "10.1016/j.jaad.2021.07.032",

language = "English",

volume = "87",

pages = "194--197",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

number = "1",

}

The impact of comorbidity identification on outcomes in patients with pyoderma gangrenosum: A retrospective cohort study of previously hospitalized patients. / Ravi, Manisha; Trinidad, John; Spaccarelli, Natalie et al.
In: Journal of the American Academy of Dermatology, Vol. 87, No. 1, 07.2022, p. 194-197.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - The impact of comorbidity identification on outcomes in patients with pyoderma gangrenosum

T2 - A retrospective cohort study of previously hospitalized patients

AU - Ravi, Manisha

AU - Trinidad, John

AU - Spaccarelli, Natalie

AU - Kaffenberger, Benjamin

N1 - Funding Information: Dr Kaffenberger is an investigator for AnaptysBio Inc, Biogen, InflaRx, Onquality Pharmaceuticals, and Eli Lilly Co and is funded by the Dermatology Foundation . Drs Trinidad and Spaccarelli and Author Ravi have no conflicts of interest to declare.

PY - 2022/7

Y1 - 2022/7

UR - https://www.scopus.com/pages/publications/85112557145

U2 - 10.1016/j.jaad.2021.07.032

DO - 10.1016/j.jaad.2021.07.032

M3 - Article

C2 - 34314745

AN - SCOPUS:85112557145

SN - 0190-9622

VL - 87

SP - 194

EP - 197

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 1

ER -

The impact of comorbidity identification on outcomes in patients with pyoderma gangrenosum: A retrospective cohort study of previously hospitalized patients

Access to Document

Other files and links

Cite this